PART I Overview Ovid is a biopharmaceutical company that is dedicated to developing small molecule medicines for brain disorders with significant unmet need. These potential medicines targeting the central nervous system (CNS) are designed to potentially halt the course of brain disease by quelling neuronal hyperexcitation and alleviating the most impactful patient symptoms. We seek to address fundamental biological targets in the brain that are implicated in neuronal hyperexcitability, such as ...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001628280-26-019438 | EDGAR | 69K words |
| 2025-03-11 | 2024-12-31 | 0001628280-25-011844 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001628280-24-009809 | EDGAR | — |
| 2023-03-13 | 2022-12-31 | 0001628280-23-007648 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003668 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001564590-21-013016 | EDGAR | — |
| 2020-03-11 | 2019-12-31 | 0001564590-20-010108 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001564590-19-006804 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001564590-18-007152 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001636651-25-000012 | EDGAR | 51K words |
| 2025-08-13 | 2025-06-30 | 0001628280-25-040008 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001628280-25-024913 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001628280-24-046868 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001628280-24-036860 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001628280-24-023067 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001628280-23-036564 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001628280-23-027430 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001628280-23-016013 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001628280-22-028772 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001628280-22-021759 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0000950170-22-008739 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-18 | 0001628280-26-019045 | EDGAR | 20K words |
| 2025-12-18 | 0001193125-25-323798 | EDGAR | — |
| 2025-12-11 | 0001636651-25-000017 | EDGAR | — |
| 2025-11-12 | 0001636651-25-000011 | EDGAR | — |
| 2025-10-03 | 0001193125-25-230409 | EDGAR | — |
| 2025-09-16 | 0001193125-25-204308 | EDGAR | — |
| 2025-08-13 | 0001628280-25-040007 | EDGAR | — |
| 2025-07-10 | 0001628280-25-034733 | EDGAR | — |
| 2025-06-25 | 0001628280-25-032959 | EDGAR | — |
| 2025-05-13 | 0001628280-25-024911 | EDGAR | — |
201 total filings indexed. 170 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001636651 |
| Ticker | OVID |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ovidrx.com |
| Listed | 2017-05-05 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/OVID (~200 tokens, structured JSON with cryptographic provenance)